Details for Patent: 9,669,008

Which drugs does patent 9,669,008 protect, and when does it expire?

Patent 9,669,008 protects EPANED and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 9,669,008

Patent landscape, scope, and claims:

Title:	Enalapril formulations
Abstract:	Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
Inventor(s):	Mosher; Gerold L. (Kansas City, MO), Miles; David W. (Kansas City, MO)
Assignee:	Silvergate Pharmaceuticals, Inc. (Greenwood Village, CO)
Application Number:	15/081,603
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,669,008
Patent Claim Types: see list of patent claims	Formulation; Compound;

Drugs Protected by US Patent 9,669,008

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Azurity	EPANED	enalapril maleate	SOLUTION;ORAL	208686-001	Sep 20, 2016	AB	RX	Yes	Yes	9,669,008		Y

International Family Members for US Patent 9,669,008

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Brazil	112018068960
European Patent Office	3429581
World Intellectual Property Organization (WIPO)	2017161339